SeaStar Medical Holding Corp (NAS:ICU)

Q1 2025 SeaStar Medical Holding Corp Earnings Call Transcript

May 14, 2025 / 08:30 PM GMT

Release Date Price: $12.3 (-3.15%)

Transcript 10-Q8-K

Key Points

Positve

SeaStar Medical Holding Corp (ICU) achieved a fourfold increase in first-quarter revenue compared to the fourth quarter of 2024.
The company added a prestigious nationally recognized children's hospital to its list of Quelmmune customers and achieved 50% enrollment in the Neutralized AKI trial.
Two new breakthrough device designations were granted by the FDA, expanding pipeline indications for adult and pediatric cardiac surgery.
The company is seeing increased adoption of its quell immune therapy, leading to organ sparing and life-saving outcomes in pediatric AKI patients.
The adult AKI market presents a significant opportunity, with a potential $4.5 billion total annual market opportunity in the United States.

Negative

The process of adoption at medical centers can be lengthy, with time to activation varying from several months to approximately 8 months.
Sales are expected to be lumpy until more pediatric hospitals are activated and the cadence of patient presentation is better understood.
The enrollment rate for the Neutralized AKI trial has been slow at times, causing delays in reaching the enrollment goal.
The company faces challenges in maintaining the integrity of the trial, as specific data from interim analyses cannot be shared.
Operating expenses increased modestly due to increased spending for commercial launch and growing enrollment in the Neutralized AKI trial.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ICU.OQ - SeaStar Medical Holding Corp
Q1 2025 SeaStar Medical Holding Corp Earnings Call
May 14, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sea Star Medical first quarter financial results conference call. All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press star, followed by the number one on your telephone keypad. If you'd like to withdraw your question, press one again.

Thank you. I would now like to turn the call over to Jackie Kaufman. Please go ahead.

------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.